GleamWall
中文EN

ADRX ADARx Pharmaceuticals, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1802369 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA—
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets38.2%
Debt / equity0.00x
Current ratio21.08x
Interest coverage—

Cash quality & payout

Operating cash flow / net income—
Accruals ratio—
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q32025-09-302025Q22025-06-302025Q12025-03-31
Income statement
Revenue$2.22M——$1.55M——
R&D expense$26.71M——$19.42M——
SG&A expense$7.68M——$5.15M——
Operating income-$32.18M——-$23.01M——
Net income-$28.12M-$25.76M-$22.67M-$17.88M-$18.09M-$15.55M
EBITDA-$31.88M——-$22.71M——
EPS (basic)-1.74——-1.85——
EPS (diluted)-1.74——-1.85——
Weighted avg. shares (diluted)16.13M——9.65M——
Balance sheet
Cash & equivalents$570.61M——$59.18M——
Short-term investments$330.40M—————
Current assets$918.51M—————
PP&E, net$4.40M—————
Total assets$929.06M—————
Current liabilities$43.57M—————
Total liabilities$354.66M—————
Shareholders' equity$574.40M-$251.05M-$225.73M-$182.92M-$166.92M-$150.92M
Shares outstanding107.26M—————
Cash flow statement
Operating cash flow——————
Depreciation & amortization$300,000——$300,000——
Stock-based compensation$1,928——$1,441——

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.